Stocks and Investing Stocks and Investing
Mon, January 22, 2024
[ 12:00 AM ] - United States, WOPRAI
Mara Goldstein Maintained (XNCR) at Strong Buy with Decreased Target to $50 on, Jan 22nd, 2024
[ 12:00 AM ] - United States, WOPRAI
Bruno Montanari Maintained (XMTR) at Strong Buy with Increased Target to $46 on, Jan 22nd, 2024
[ 12:00 AM ] - United States, WOPRAI
Kenneth Lee Maintained (AMP) at Buy with Increased Target to $420 on, Jan 22nd, 2024
[ 12:00 AM ] - United States, WOPRAI
Jeff Grampp Initiated (AMPY) at Strong Buy and Held Target at $9 on, Jan 22nd, 2024
[ 12:00 AM ] - United States, WOPRAI
Thomas Blakey Maintained (ANET) at Buy with Increased Target to $306 on, Jan 22nd, 2024
[ 12:00 AM ] - United States, WOPRAI
Daniel Kurnos Maintained (AMZN) at Strong Buy with Increased Target to $175 on, Jan 22nd, 2024
[ 12:00 AM ] - United States, WOPRAI
Eric Sheridan Maintained (ANGI) at Strong Buy with Decreased Target to $3 on, Jan 22nd, 2024
[ 12:00 AM ] - United States, WOPRAI
Shahriar Pourreza Upgraded (AVA) to Hold and Held Target at $34 on, Jan 22nd, 2024
[ 12:00 AM ] - United States, WOPRAI
Gil Blum Maintained (AUTL) at Strong Buy with Increased Target to $8 on, Jan 22nd, 2024
[ 12:00 AM ] - United States, WOPRAI
William Plovanic Maintained (ATEC) at Strong Buy with Increased Target to $25 on, Jan 22nd, 2024
[ 12:00 AM ] - United States, WOPRAI
Danielle Antalffy Maintained (ATRC) at Strong Buy with Increased Target to $57 on, Jan 22nd, 2024
[ 12:00 AM ] - United States, WOPRAI
Eric Beaumont Maintained (ATO) at Hold with Decreased Target to $115 on, Jan 22nd, 2024
[ 12:00 AM ] - United States, WOPRAI
Joseph Stringer Maintained (CARA) at Strong Buy with Decreased Target to $5 on, Jan 22nd, 2024
[ 12:00 AM ] - United States, WOPRAI
Mark Zgutowicz Initiated (CART) at Strong Buy and Held Target at $32 on, Jan 22nd, 2024
[ 12:00 AM ] - United States, WOPRAI
James Thalacker Maintained (AEP) at Buy with Decreased Target to $88 on, Jan 22nd, 2024
[ 12:00 AM ] - United States, WOPRAI
Eric Beaumont Maintained (AEP) at Buy with Increased Target to $84 on, Jan 22nd, 2024
[ 12:00 AM ] - United States, WOPRAI
Shahriar Pourreza Downgraded (AEP) to Hold and Held Target at $81 on, Jan 22nd, 2024
[ 12:00 AM ] - United States, WOPRAI
Stephen Byrd Maintained (AES) at Buy with Increased Target to $21 on, Jan 22nd, 2024
[ 12:00 AM ] - United States, WOPRAI
Jason Celino Maintained (ADSK) at Buy with Increased Target to $265 on, Jan 22nd, 2024
[ 12:00 AM ] - United States, WOPRAI
Ben Kallo Downgraded (ADM) to Hold and Decreased Target to $61 on, Jan 22nd, 2024
[ 12:00 AM ] - United States, WOPRAI
Adam Samuelson Downgraded (ADM) to Hold and Decreased Target to $67 on, Jan 22nd, 2024
[ 12:00 AM ] - United States, WOPRAI
Andrew Strelzik Maintained (ADM) at Hold with Decreased Target to $66 on, Jan 22nd, 2024
[ 12:00 AM ] - United States, WOPRAI
Brian Wright Downgraded (ADM) to Hold and Decreased Target to $66 on, Jan 22nd, 2024
[ 12:00 AM ] - United States, WOPRAI
Vincent Anderson Downgraded (ADM) to Hold and Decreased Target to $56 on, Jan 22nd, 2024
[ 12:00 AM ] - United States, WOPRAI
Benjamin Theurer Downgraded (ADM) to Sell and Decreased Target to $60 on, Jan 22nd, 2024
[ 12:00 AM ] - United States, WOPRAI
Anthony Petrone Maintained (ADMA) at Strong Buy with Increased Target to $9 on, Jan 22nd, 2024
[ 12:00 AM ] - United States, WOPRAI
Raghuram Selvaraju Downgraded (ACRS) to Hold on, Jan 22nd, 2024
[ 12:00 AM ] - United States, WOPRAI
Mitch Germain Upgraded (ADC) to Buy and Held Target at $71 on, Jan 22nd, 2024
[ 12:00 AM ] - United States, WOPRAI
Charles Duncan Reiterated (AXSM) at Buy and Held Target at $108 on, Jan 22nd, 2024
[ 12:00 AM ] - United States, WOPRAI
Josh Schimmer Reiterated (BBIO) at Buy and Held Target at $50 on, Jan 22nd, 2024

Josh Schimmer Reiterated (BBIO) at Buy and Held Target at $50 on, Jan 22nd, 2024


Published on 2024-10-28 08:27:33 - WOPRAI, Josh Schimmer
  Print publication without navigation


Josh Schimmer of Cantor Fitzgerald, Reiterated "BridgeBio Pharma, Inc." (BBIO) at Buy and Held Target at $50 on, Jan 22nd, 2024.

Josh has made no other calls on BBIO in the last 4 months.



There is 1 other peer that has a rating on BBIO. Out of the 1 peers that are also analyzing BBIO, 0 agree with Josh's Rating of Hold.



This is the rating of the analyst that currently disagrees with Josh

  • David Lebowitz of "Citigroup" Initiated at Strong Buy and Held Target at $42 on, Tuesday, November 7th, 2023

Contributing Sources
    D885FD0B-4D59-419D-81DE-3DF4BF5AB503
  • support@woprai.com